semaglutide for kidney failure just got FDA-approved disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in AHA 2024: semaglutide continues to

For some adult kids, a different worry: Parents misusing GLP-1s At the opposite end of the spectrum are adult children who wring their hands while watching their parents shrink

Seek urgent medical attention if night sweats occur with: Drenching sweats with high fever Chest pain or severe shortness of breath Confusion or disorientation Severe symptoms in immunocompromised individuals Contact your healthcare provider if night sweats occur with: Unexplained weight loss (beyond expected weight loss from GLP-1 therapy) Persistent fever or chills Fatigue that interferes with daily activities Enlarged lymph nodes Persistent cough Changes in bowel habits or blood in stool (if other concerning symptoms are present) For patients with diabetes, symptoms suggesting hypoglycemia during sleep episodes require prompt evaluation

Shelf life Unopened vials: Typically stable for 12-24 months from compounding date

Studies show that even losing a small amount of weight can lower the frequency and severity of gout attacks